Baird Medical Investment Holdings Limited (BDMD) Research

Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.

Market snapshot

Symbol
BDMD
Price
$1.11
Day change
-4.31%
Market cap
$45.5M
P/E ratio
-1.17x
52-week range
0.757-7.262
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Biodesix, Inc. (BDSX)
  • HeartBeam, Inc. (BEAT)
  • Cytosorbents Corporation (CTSO)
  • electroCore, Inc. (ECOR)
  • FibroGen, Inc. (FGEN)
  • IceCure Medical Ltd (ICCM)
  • NeuroOne Medical Technologies Corporation (NMTC)
  • Inotiv, Inc. (NOTV)

Recent insider activity

  • Xu Lijian — trade (0 shares) on 2026-04-21
  • Qiu Quan — trade (0 shares) on 2026-04-21
  • Lu Rongjian — trade (0 shares) on 2026-04-21
  • Bilciu-Wolfson Gabrielle — trade (0 shares) on 2026-03-18
  • Li Jie Clara — trade (0 shares) on 2026-04-15

Open Baird Medical Investment Holdings Limited (BDMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.